Lv1
60 积分 2025-04-09 加入
Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer
9小时前
已完结
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
2个月前
已完结
Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study
2个月前
已完结
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022
2个月前
已完结
Is it appropriate to select patients for primary prophylactic use of pegfilgrastim based on the risk of febrile neutropenia?
2个月前
已完结
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer
2个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
3个月前
已完结
不同剂量PEG-rhG-CSF临床疗效、安全性和最小成本分析
3个月前
已完结
不同剂量PEG-rhG-CSF临床疗效、安全性和最小成本分析
3个月前
已完结
Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer
3个月前
已完结
皖公网安备34019202002308
